BioNTech acquired the Marburg facility in 2020 from Novartis AG, which had used it to produce complex biological medicines.

The pace of the growth is putting a premium on logistics capabilities, including distribution centers positioned to quickly reach U.S. customers.

Lilly is looking to double its capacity to make drugs that mimic incretin, a hormone that gives the sensation of having eaten, by the end of the year.

CVS’s drugstore chain is coping with headwinds that include diminished concerns about the pandemic, which has translated into fewer visits for COVID-19 tests and vaccinations.

The country has so far relied almost solely on homegrown medicines and vaccines to shore up immunity and treat COVID patients. 

Access this e-book from Tecsys to learn about the advantages of a modern warehouse design process and the value of participation from all relevant parties.

In 2020 several disruptive events shifted strategic supply chain priorities. An end-to-end approach for supply chain resiliency is imperative to tackle future industry challenges and disruptive events.